Falken Industries Ltd
OTC Bulletin Board : FLKI

Falken Industries Ltd

December 14, 2011 09:40 ET

FLKI's Brilliance and Professional Lines Continue Their Expansion With Record Activity at the Clean Plus® Product Group

Record Breaking Sales Are Projected for 2012 With No Sacrifice to Margins

TRENTON, NEW JERSEY--(Marketwire - Dec. 14, 2011) - FALKEN Industries Ltd (OTCBB:FLKI), has experienced a tremendous surge in popularity for a number of its product conceptions, and notably those in the Professional Line of its Car Care collection. The line includes its unparalleled Brilliance collection.

FALKEN whose renown in the industry as a "trend-setter" is oft' commented, has been innovating successfully since 1997 when it launched a consumer product conception designed to prove its contrarian pretention at the time, that women, and not the industry's model "macho man", would constitute the major market for Auto Care. "The Clean Plus® "Premium" collection was born of that effort" says Manuel Garcia, communications officer. The product line, first to introduce for Auto Care a collection of convenient wipes, has been a and continues to be a dramatic success. Added Garcia : "The company is now forewarning an all-kill in the automobile after-market industry with the release of their new, enhanced, professional car care product lines, which includes products such as Brilliance, unique compounds that successfully compete with the well-known, but considerably more expensive, 3M and Dupont competitor products in tens of thousands of Auto-body Shops, and Detailing Centers."

On September 26th, FALKEN's enhanced Professional Car Care line with 10 new products conceived from FLKI original research and development. "This release brought to 13 the total number of new exciting products that are sure to capture the heart of distributors, retailers and End-users" said Garcia.

The products have already started to prove themselves and continue to rise in popularity. The products are designed to be high performance, easy to use, time saving and accessible in price for every-one, not just high-end end-users.

With this winning portfolio of innovative products, record breaking sales are projected for 2012 with no sacrifice to margins. In its most recent third quarter ending September 30, 2011, the company earned 1 cent per share (EPS) while its stock price is currently 0.045 (PPS).

About Falken Industries Ltd:

Falken Industries Ltd (OTCBB:FLKI) is a diversified industrial conglomerate that operates in Chemicals, Wet Wipe and Biodegradable Technology. Falken Industries Ltd is the concept behind more than 160 products distributed through a network of global platforms and the recipient of trade awards for innovations, biodegradability and environmental and health quality standards. As a reliable partner FLKI creates chemistry to help distributors and retailers in virtually all industries to be more successful. With its high-value products and intelligent solutions, FLKI plays an important role in finding answers to global challenges such as environmental protection, energy efficiency, and mobility.

SAFE HARBOR STATEMENT: This news release contains "forward-looking statements" made pursuant to the safe harbor provisions of the 1995 Private Securities Litigation Reform Act. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." Such statements are subject to risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that our products may not achieve customer acceptance or perform as intended, that we may be unable to obtain necessary financing to continue operations and development, and other risks. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

Contact Information